Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Clinical efficacy and emerging therapeutic utilization of novel taxanes
William Gradishar
*
, Javier Cortes
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical efficacy and emerging therapeutic utilization of novel taxanes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
16%
Albumin-bound
16%
Anticancer Agents
16%
Antitumor Efficacy
16%
Bound Form
16%
Breast
16%
Breast Cancer Treatment
16%
Cancer Treatment
33%
Clinical Application
16%
Clinical Efficacy
100%
Emerging Therapeutics
100%
In Cancer
33%
Lung Cancer Treatment
16%
Melanoma
16%
Mid-1990s
16%
Monotherapy
16%
Nab-paclitaxel
50%
Ovarian Cancer
16%
Paclitaxel
16%
Pancreatic Cancer
16%
Parenteral Administration
16%
Prostate Cancer
33%
Solid Tumors
16%
Solvent-based
16%
Solvent-free
16%
Taxanes
100%
Treatment Efficacy
16%
Treatment Regimen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
16%
Anticarcinogen
16%
Breast Cancer
16%
Combination Therapy
16%
Lung Cancer
16%
Malignant Neoplasm
33%
Melanoma
16%
Monotherapy
16%
Ovary Cancer
16%
Paclitaxel
66%
Pancreas Cancer
16%
Prostate Cancer
16%
Solid Malignant Neoplasm
16%
Taxane
100%